EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 3
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Volume 14 Issue 3

How to Hire a Translation Agency

Choosing the right medical translation provider can help in-house regulatory and clinical departments and contract research organisations support strategic growth whi...
21 June 2022 Volume 14 Issue 3
Continue Reading →
Regional News

Covis’ controversial Makena gets FDA hearing date in bid to stay on the market

More than a decade after Makena's FDA approval to prevent recurrent preterm birth and two years after the FDA recommended the drug be pulled from the market, Covis Ph...
16 June 2022 Regional News
Continue Reading →
Regional News

FDA staff reveal flaws with Acadia’s 2nd Nuplazid try in Alzheimer’s psychosis

The FDA is poking holes in Acadia Pharmaceuticals’ second try for expanding Nuplazid into a new neurological disorder—and in doing so, the agency has revealed a chasm...
16 June 2022 Regional News
Continue Reading →
Regional News

Moderna’s COVID vaccine wins unanimous FDA panel backing for kids 6 to 17

After an all-day meeting, an FDA advisory committee unanimously voted to recommend Moderna's two-dose COVID-19 vaccine for kids ages 6 to 17. This means an FDA author...
16 June 2022 Regional News
Continue Reading →
Regional News

Pfizer runs first Cibinqo eczema TV ad as it forgoes actors and leans heavily on a blue hue

Pfizer launched its first TV commercial for its new psoriasis therapy Cibinqo, and it’s giving us the blues. You may be forgiven for thinking Pfizer had left a ge...
16 June 2022 Regional News
Continue Reading →
Regional News

Genentech’s spinal muscular atrophy song played at Special Olympics Florida closing ceremony

Genentech's campaign song by James Ian, which debuted last November, played at the Olympics closing ceremony this month because of the song's message of inclusivity. ...
16 June 2022 Regional News
Continue Reading →
Regional News

Eli Lilly’s Olumiant snags biopharma’s first FDA green light for alopecia areata

Eli Lilly’s commitment to the immunology field has paid off with another important approval for JAK inhibitor Olumiant. And it's an industry first in alopecia areata....
16 June 2022 Regional News
Continue Reading →
Regional News

Almirall, ramping up its Klisyri launch, wants patients to ‘listen to what your marks whisper to you’

As Almirall looks to ramp up its Klisyri launch, the pharma is organizing an inaugural awareness day for the skin condition it treats. Actinic Keratosis Global Day h...
31 May 2022 Regional News
Continue Reading →
Regional News

GSK’s ViiV to work with Medicines Patent Pool, generic manufacturers to bolster access to long-acting HIV prevention med Apretude

Hot on the heels of Pfizer’s access accord, GSK’s ViiV Healthcare is teaming up with its old friend the Medicines Patent Pool (MPP) to broaden access to its latest HI...
31 May 2022 Regional News
Continue Reading →
Regional News

PharmaTher fleshes out ketamine delivery portfolio with deal for on-body injector

The ketamine drug delivery deals keep coming. PharmaTher is again involved in the latest agreement, teaming up with CC Biotechnology Corporation (CCBIO) to access a w...
31 May 2022 Regional News
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2025, All Rights Reserved – Powered by Teksyte